Related Experiment Video
Updated: Aug 3, 2026

Permanent Cerebral Vessel Occlusion via Double Ligature and Transection
Published on: July 21, 2013
Occluded infarct-related arteries and clinical events
M Lund1, J K French, H D White
1Cardiovascular Research Unit, Green Lane Hospital, Auckland, New Zealand.
Insights
Opening persistently blocked heart arteries after a heart attack may improve survival. A large trial is needed to compare artery opening procedures with medication alone for long-term outcomes.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Late patency of the infarct-related artery (IRA) correlates with improved survival in observational studies.
- Randomized trials are lacking to confirm the clinical benefits of opening persistently occluded IRAs.
- Advances in percutaneous revascularization have enhanced safety and reduced restenosis/reocclusion rates.
Purpose of the Study:
- To address the need for a randomized trial evaluating percutaneous revascularization versus medical management for occluded IRAs.
- To assess clinical outcomes in patients with occluded IRAs without inducible ischemia.
Main Methods:
- A large-scale randomized controlled trial is proposed.
- Comparison between percutaneous revascularization and medical management strategies.
- Focus on patients with persistently occluded infarct-related arteries.
Main Results:
- Observational data suggest improved survival with late IRA patency.
- Percutaneous revascularization techniques have demonstrated improved safety and efficacy.
- Further research is required to establish definitive clinical outcomes from randomized trials.
Conclusions:
- A definitive randomized trial is necessary to guide treatment decisions for occluded IRAs.
- Evaluating percutaneous revascularization against medical management is crucial for optimizing patient care.
- Evidence from observational studies highlights the potential benefits of maintaining IRA patency.
Abstract:
Late patency of the infarct-related artery has been shown to be associated with improved long-term survival rates in observational cohort studies. However, there is a dearth of randomized trials correlating the opening of persistently occluded infarct-related arteries with clinical outcomes. Recent technological advances have improved the success and safety of percutaneous revascularization, resulting in lower restenosis and reocclusion rates. A large randomized trial is needed to evaluate clinical outcomes with percutaneous revascularization versus medical management of occluded infarct-related arteries in the absence of inducible ischemia.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction

